Ausgewählte Publikationen von Mitgliedern der Arbeitsgruppe im Bereich Botulinum Toxin und Dystonie

Kranz G, Sycha T, Voller B, Kranz GS, Schnider P, Auff E. Neutralizing antibodies in dystonic patients who still respond well to botulinum toxin type A. Neurology 2008; 70: 133-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18180443

 

Hering S, Wenning GK, Seppi K, Poewe W, Mueller J. An open trial of levetiracetam for segmental and generalized dystonia. Mov Disord 2007; 22: 1649-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17557353

 

Muller J, Rinnerthaler M, Poewe W, Kofler M. Auditory startle reaction in primary blepharospasm. Mov Disord 2007; 22: 268-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17149731

 

Muller UJ, Frick B, Winkler C, Fuchs D, Wenning GK, Poewe W, et al. Homocysteine and serum markers of immune activation in primary dystonia. Mov Disord 2005; 20: 1663-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16108020

 

Muller J, Wissel J, Kemmler G, Voller B, Bodner T, Schneider A, et al. Craniocervical dystonia questionnaire (CDQ-24): development and validation of a disease-specific quality of life instrument. J Neurol Neurosurg Psychiatry 2004; 75: 749-53. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15090572

 

Sycha T, Kranz G, Auff E, Schnider P. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature. J Neurol 2004; 251 Suppl 1: I19-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14991339

 

Voller B, Moraru E, Auff E, Benesch M, Poewe W, Wissel J, et al. Ninhydrin sweat test: a simple method for detecting antibodies neutralizing botulinum toxin type A. Mov Disord 2004; 19: 943-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15300661

 

Muller J, Kofler M, Wenning GK, Seppi K, Valls-Sole J, Poewe W. Auditory startle response in cervical dystonia. Mov Disord 2003; 18: 1522-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14673891

 

Homann CN, Wenzel K, Kriechbaum N, Suppan K, Crevenna R, Ivanic G, et al. [Botulinum toxin--the dose controls the poison. A historical sketch]. Nervenarzt 2002; 73: 519-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12242998

 

Moraru E, Schnider P, Wimmer A, Wenzel T, Birner P, Griengl H, et al. Relation between depression and anxiety in dystonic patients: implications for clinical management. Depress Anxiety 2002; 16: 100-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12415533

 

Muller J, Kemmler G, Wissel J, Schneider A, Voller B, Grossmann J, et al. The impact of blepharospasm and cervical dystonia on health-related quality of life and depression. J Neurol 2002; 249: 842-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12140667

 

Muller J, Wenning GK, Wissel J, Baldauf A, Seppi K, Brenneis C, et al. Riluzole therapy in cervical dystonia. Mov Disord 2002; 17: 198-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11835465

 

Muller J, Wenning GK, Wissel J, Seppi K, Poewe W. Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia. J Neurol 2002; 249: 300-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11993530

 

Poewe W. Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry 2002; 72: 430. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11909897

 

Muller J, Ebersbach G, Wissel J, Poewe W. Dynamic balance function in phasic cervical dystonia following Botulinum toxin therapy. Mov Disord 2001; 16: 934-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11746626

 

Muller J, Wissel J, Masuhr F, Ebersbach G, Wenning GK, Poewe W. Clinical characteristics of the geste antagoniste in cervical dystonia. J Neurol 2001; 248: 478-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11499637

 

Sojer M, Wissel J, Muller J, Poewe W. [Treatment of focal dystonia with botulinum toxin A]. Wien Klin Wochenschr 2001; 113 Suppl 4: 6-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15506045

 

Wissel J, Kanovsky P, Ruzicka E, Bares M, Hortova H, Streitova H, et al. Efficacy and safety of a standardised 500 unit dose of Dysport (clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study. J Neurol 2001; 248: 1073-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12013585

 

Fertl E, Schnider P, Schneider B, Auff E. Remote effects of chronic botulinum toxin treatment: electrophysiologic results Do not indicate subclinical remodelling of noninjected muscles. Eur Neurol 2000; 44: 139-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11053960

 

Birner P, Schnider P, Muller J, Wissel J, Fuchs I, Auff E. [Torticollis spasmodicus, blepharospasm and hemifacial spasm. Subjective evaluation of therapy by patients]. Nervenarzt 1999; 70: 903-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10554782

 

Muller J, Ebersbach G, Wissel J, Brenneis C, Badry L, Poewe W. Disturbances of dynamic balance in phasic cervical dystonia. J Neurol Neurosurg Psychiatry 1999; 67: 807-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10567505

 

Schnider P, Birner P, Moraru E, Auff E. [Long-term treatment with botulinum toxin: dosage, treatment schedules and costs]. Wien Klin Wochenschr 1999; 111: 59-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10081123

 

Schnider P, Voller B, Moraru K, Auff E. [Botulinum toxin therapy: from dreaded biological toxin to standard pharmaceutical]. Wien Klin Wochenschr 1999; 111: 825-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10586486

 

Wissel J, Muller J, Ebersbach G, Poewe W. Trick maneuvers in cervical dystonia: investigation of movement- and touch-related changes in polymyographic activity. Mov Disord 1999; 14: 994-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10584675

 

Wissel J, Muller J, Heinen F, Mall V, Sojer M, Ebersbach G, et al. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group]. Wien Klin Wochenschr 1999; 111: 837-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10586488

 

Wober C, Schnider P, Steinhoff N, Trattnig S, Zebenholzer K, Auff E. Posturographic findings in patients with idiopathic cervical dystonia before and after local injections with botulinum toxin. Eur Neurol 1999; 41: 194-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10343149

 

Poewe W, Deuschl G, Nebe A, Feifel E, Wissel J, Benecke R, et al. What is the optimal dose of botulinum toxin A in the treatment of cervical dystonia? Results of a double blind, placebo controlled, dose ranging study using Dysport. German Dystonia Study Group. J Neurol Neurosurg Psychiatry 1998; 64: 13-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9436721

 

Scheidt CE, Rayki O, Nickel T, Heinen F, Wissel J, Poewe W, et al. [Psychosomatic aspects of idiopathic spasmodic torticollis. Results of a multicenter study]. Psychother Psychosom Med Psychol 1998; 48: 1-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9499714

 

Wissel J, Masuhr F, Schelosky L, Ebersbach G, Poewe W. Quantitative assessment of botulinum toxin treatment in 43 patients with head tremor. Mov Disord 1997; 12: 722-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9380055

 

Nebe A, Schelosky L, Wissel J, Ebersbach G, Scholz U, Poewe W. No effects on heart-rate variability and cardiovascular reflex tests after botulinum toxin treatment of cervical dystonia. Mov Disord 1996; 11: 337-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8723158

 

Wissel J, Kabus C, Wenzel R, Klepsch S, Schwarz U, Nebe A, et al. Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. J Neurol Neurosurg Psychiatry 1996; 61: 172-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8708685

 

Poewe W, Wissel J. Use of botulinum toxin in the treatment of cervical dystonia. Baillieres Clin Neurol 1993; 2: 179-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8143072

 

Poewe W, Schelosky L, Kleedorfer B, Heinen F, Wagner M, Deuschl G. Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients. J Neurol 1992; 239: 21-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1541964

 

Wissel J, Poewe W. Dystonia--a clinical, neuropathological and therapeutic review. J Neural Transm Suppl 1992; 38: 91-104. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1491251